Supplementary report: surveillance of adverse events following immunisation among children aged <7 years in Australia, 1 January to 30 June 2008

Authors

  • Glenda L Lawrence School of Public Health and Community Medicine, University of New South Wales, Sydney, New South Wales; National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children's Hospital at Westmead, Sydney, New South Wales
  • Deepika Mahajan National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children's Hospital at Westmead, Sydney, New South Wales
  • Ilnaz Roomiani Therapeutic Goods Administration, Canberra, Australian Capital Territory

DOI:

https://doi.org/10.33321/cdi.2009.33.4

Keywords:

AEFI, surveillance, immunisation, vaccine safety

Abstract

The adverse events following immunisation surveillance aims to monitor vaccine and immunisation program safety and to detect population-specific, rare, late-onset or unexpected adverse events that may not be detected in pre-licensure vaccine trials. This report summarises national passive adverse events following immunisation (AEFI) surveillance data for children aged less than 7 years who received vaccines between 1 January and 30 June 2008 and is a supplement to the annual reports for each year.

Downloads

Download data is not yet available.

References

National Health and Medical Research Council. The Australian immunisation handbook. 9th ed. Canberra: Australian Government Department of Health and Ageing, 2008.

State Government of Victoria, Department of Human Services. SAEFVIC: Surveillance of adverse events following vaccination in the community. Available from: http://www.health.vic.gov.au/immunisation/general/saefvic Accessed on January 2009.

Pym M, Adams J, Booy R et al. The development and trial of paediatric active enhanced disease surveillance (PAEDS): A new surveillance mechanism for Australia. Presented at the Royal Australasian College of Physicians Congress, Adelaide, 11–15 May 2008.

Australian Government Department of Health and Ageing. Immunisation programs and initiatives. Available from: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/programs Accessed January 2009.

CDC. Continued Shortage of Haemophilus influenzae Type b (Hib) Conjugate vaccines and potential implications for Hib surveillance – United States, 2008. MMWR Morb Mortal Wkly Rep 2008;57:1252–1255.

Queensland Department of Health. National Immunisation Program Schedule change for Queensland, March 2008. Available from: http://www.health.qld.gov.au/ph/Documents/cdb/imm_sched_gp.pdf Accessed January 2009.

Immunisation Section Department of Health, South Australia. Quarterly newsletter March 2008. Available from: http://www.dh.sa.gov.au/pehs/Immunisation/0803-sharp-point-news.pdf Accessed January 2009.

Department of Health and Human Services, Victoria. Immunisation Newsletter, January 2008. Available from: http://www.health.vic.gov.au/__data/assets/pdf_file/0015/130083/Immunisation-newsletter-issue-32.pdf Accessed January 2009.

Communicable Disease Control Directorate, Department of Health,-Government of Western Australia. March 2008. Available from: http://www.canningdivision.com.au/cdgp_docs/immunisation/CHANGE%20IN%20WA%20VACCINATION%20SCHEDULE%20DUE%20TO%20PEDVAX%20SHORTAGE.pdf Accessed January 2009.

Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, et al. Surveillance of adverse events following immunisation: Australia, 2000–2002. Commun Dis Intell 2003;27:307–323.

Lawrence G, Aratchige PE, Hill R. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2007. Commun Dis Intell 2007;31:379–382.

Lawrence GL, Gold MS, Hill R, Deeks S, Glasswell A, McIntyre PB. Annual report on surveillance of adverse events following immunisation in Australia, 2007. Commun Dis Intell 2008;32:371–386.

Lawrence G, Boyd I. Supplementary report: surveillance of adverse events following immunisation among children aged <7 years in Australia, 1 January to 30 June 2006. Commun Dis Intell 2006; 30:438–442.

Gold MS, Noonan S, Osbourn M, Precepa S, Kempe AE. Local reactions after the fourth-dose of acellular pertussis vaccine in South Australia. Med J Aust 2003;179:191–194.

Rennels MB, Deloria MA, Pichichero ME, Losonsky GA, Englund JA, Meade BD, et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 2000;105:e12.

Downloads

Published

01/03/09

How to Cite

Lawrence, Glenda L, Deepika Mahajan, and Ilnaz Roomiani. 2009. “Supplementary Report: Surveillance of Adverse Events Following Immunisation Among Children Aged <7 Years in Australia, 1 January to 30 June 2008”. Communicable Diseases Intelligence 33 (March):27-31. https://doi.org/10.33321/cdi.2009.33.4.

Issue

Vol. 33 (2009)

Section

Surveillance summary

Categories

License

Copyright (c) 2009 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 > >>